DAILY ASPIRIN THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Wilechansky, Robert M. [1 ]
Stoyanova, Stefania [1 ]
Grossman, Alessandra [1 ]
Dichtel, Laura E. [1 ]
Serhan, Charles N. [2 ]
Miller, Karen K. [1 ]
Corey, Kathleen E. [1 ]
Chung, Raymond T. [1 ]
Chan, Andrew T. [1 ]
Simon, Tracey G. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
144
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [41] Galanin Receptors as Target for Drug Therapy of Metabolic Dysfunction-associated Steatotic Liver Disease
    Mireles, Patrick
    Green, Kaden
    Petrescu, Anca D.
    An, Su Yeon
    Venter, Julie
    Nadeem, Yusra
    DeMorrow, Sharon
    AMERICAN JOURNAL OF PATHOLOGY, 2024, 194 (04): : S20 - S21
  • [42] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [43] Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease
    Smith, Martha R.
    Yu, Elizabeth L.
    Malki, Ghattas J.
    Newton, Kimberly P.
    Goyal, Nidhi P.
    Heskett, Karen M.
    Schwimmer, Jeffrey B.
    PLOS ONE, 2024, 19 (12):
  • [44] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Elshaer, Amani
    Chascsa, David M. H.
    Lizaola-Mayo, Blanca C.
    LIFE-BASEL, 2024, 14 (07):
  • [45] SYSTEMATIC REVIEW OF EXERCISE FOR THE TREATMENT OF PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Smith, Martha
    Yu, Elizabeth
    Malki, Ghattas
    Newton, Kimberly
    Goyal, Nidhi
    Heskett, Karen
    Schwimmer, Jeffrey
    HEPATOLOGY, 2024, 80 : S1949 - S1950
  • [46] The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
    Wang, Li Jun
    Sun, Jian Guang
    Chen, Shu Cheng
    Sun, Yu Li
    Zheng, Yang
    Feng, Jian Chao
    FRONTIERS IN MEDICINE, 2025, 11
  • [47] Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease
    Long, Qichen
    Luo, Fengming
    Li, Binghui
    Li, Ziyang
    Guo, Zhe
    Chen, Zhiyang
    Wu, Weimin
    Hu, Min
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (03)
  • [48] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [49] Liver-muscle crosstalk in metabolic dysfunction-associated steatotic liver disease
    Fumo, A. R.
    Morigny, P.
    Ji, H.
    Maida, A.
    von Toerne, C.
    Alfaro, A. J.
    Motzler, K.
    Feuchtinger, A.
    Rohm, M.
    DIABETOLOGIA, 2024, 67 : S459 - S459
  • [50] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
    Sawada, Keisuke
    Chung, Hak
    Softic, Samir
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    CELL METABOLISM, 2023, 35 (11) : 1852 - 1871
12345